SCM
MACK

Sio Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Sio Capital Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-288,466
Closed -$3.87M – 68
2023
Q4 		$3.87M Hold
288,466
– – 1% 20
2023
Q3 		$3.56M Sell
288,466
-2,283
-0.8% -$27.6K 1.1% 27
2023
Q2 		$3.58M Buy
290,749
+17,906
+7% +$224K 1.26% 24
2023
Q1 		$3.35M Buy
272,843
+22,843
+9% +$268K 1.66% 15
2022
Q4 		$2.87M Buy
+250,000
New +$2.06M 1.53% 19

Other funds holding MACK

WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.84B AUM 18.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return